Prenatal exposure to the viral mimetic poly I:C alters fetal brain cytokine expression and postnatal behaviour

Developmental Neuroscience

Volumn 36, Issue 2, 2014, Pages 83-94

  Ratnayake, Udani ^a,b   Quinn, Tracey ^a   Larosa, Domenic A ^a   Dickinson, Hayley ^a   Walker, David W ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Behaviour; Cytokines; Mental illness; Poly I:C; Prenatal exposure; Spiny mouse

Indexed keywords

POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BRAIN; CONTROLLED STUDY; DOWN REGULATION; EXPLORATORY BEHAVIOR; FEAR; FEMALE; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PREPULSE INHIBITION; PRIORITY JOURNAL; SENSORY GATING; SOCIAL INTERACTION; WEIGHT REDUCTION; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NEWBORN; PREGNANCY; TOXICITY; BRAIN DEVELOPMENT; GENE EXPRESSION; GESTATIONAL AGE; MAZE TEST; NOVEL OBJECT RECOGNITION TEST; OPEN FIELD TEST; ORGANOGENESIS; PROGENY; PROTEIN EXPRESSION; SOCIAL INTERACTION TEST;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LEARNING; MEMORY; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84903632995     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000362205     Document Type: Article

References (94)

1. Brown AS, et al: Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull 2000; 26: 287-295. (Pubitemid 30423209)
2. Brown AS, et al: Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry 2000; 157: 438-443. (Pubitemid 30145931)
3. Brown AS, et al: Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61: 774-780. (Pubitemid 39031117)
4. Brown AS, et al: Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162: 767-773. (Pubitemid 40489141)
5. Buka SLS, et al: Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001; 58: 1032-1037.
6. Fuller Torrey E, Rawlings R, Waldman IN: Schizophrenic births and viral diseases in two states. Schizophr Res 1988; 1: 73-77.
7. Mortensen PB, et al: Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007; 61: 688-693. (Pubitemid 46328861)
8. Suvisaari J, et al: Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 1999; 156: 1100-1102. (Pubitemid 29302809)
9. Babulas V, et al: Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 2006; 163: 927-929. (Pubitemid 44464544)
10. Watanabe Y, Someya T, Nawa H: Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci 2010; 64: 217-230.
11. Ashdown H, et al: The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 2006; 11: 47-55. (Pubitemid 43251087)
12. Meyer U, Feldon J, Yee BK: A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 2009; 35: 959-972.
13. Gilmore J, Jarskog LF: Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 1997; 24: 365-367.
14. Cunningham C, et al: The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 2007; 21: 490-502. (Pubitemid 46528682)
15. Gandhi R, et al: Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain Behav Immun 2007; 21: 477-489. (Pubitemid 46528681)
16. Fortier ME, et al: The viral mimic, polyinosinic: polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2004; 287:R759-R766.
17. Zuckerman L, et al: Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003; 28: 1778-1789. (Pubitemid 41070843)
18. Meyer U, et al: Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005; 29: 913-947. (Pubitemid 41097394)
19. Zuckerman L, Weiner I: Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005; 39: 311-323. (Pubitemid 40255916)
20. Ozawa KK, et al: Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 2006; 59: 546-554.
21. Wolff AR, Bilkey DK: Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav Brain Res 2008; 190: 156-159.
22. Makinodan M, et al: Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 2008; 86: 2190-2200.
23. Howland JG, Cazakoff BN, Zhang Y: Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy. Neuroscience 2012; 201: 184-198.
24. Schwendener S, Meyer U, Feldon J: Deficient maternal care resulting from immunological stress during pregnancy is associated with a sex-dependent enhancement of conditioned fear in the offspring. J Neurodev Disord 2009; 1: 15-32.
25. de Miranda J, et al: Induction of Toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. MBio 2010; 1: e00176-10.
26. Clancy B, Darlington RB, Finlay BL: Translating developmental time across mammalian species. Neuroscience 2001; 105: 7-17. (Pubitemid 32722089)
27. Dickinson H, et al: The spiny mouse (Acomys cahirinus) completes nephrogenesis before birth. Am J Physiol Renal Physiol 2005; 289:F273-F279. (Pubitemid 41003656)
28. Oosterhuis WWP, et al: Perinatal development of the lung in rat and spiny mouse: its relation to altricial and precocial timing of birth. Biol Neonate 1984; 45: 236-243.
29. Lamers WH, et al: Perinatal development of the liver in rat and spiny mouse: its relation to altricial and precocial timing of birth. Eur J Biochem 1985; 146: 475-480. (Pubitemid 15168869)
30. Brunjes PC, Korol DL, Stern KG: Prenatal neurogenesis in the telencephalon of the precocial mouse Acomys cahirinus . Neurosci Lett 1989; 107: 114-119.
31. Brunjes PC: A stereological study of neocortical maturation in the precocial mouse, Acomys cahirinus . Brain Res 1985; 351: 279-287. (Pubitemid 15085402)
32. Quinn TA, et al: Ontogeny of the adrenal gland in the spiny mouse, with particular reference to production of the steroids cortisol and dehydroepiandrosterone. Endocrinology 2013; 154: 1190-1201.
33. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
34. Alexopoulou L, et al: Recognition of doublestranded RNA and activation of NF-B by Toll-like receptor 3. Nature 2001; 413: 732-738. (Pubitemid 33009951)
35. Koga K, Mor G: Expression and function of toll-like receptors at the maternal-fetal interface. Reprod Sci 2008; 15: 231-242. (Pubitemid 351550944)
36. Takeuchi O, Akira S: Recognition of viruses by innate immunity. Immunol Rev 2007; 220: 214-224. (Pubitemid 350045565)
37. Ashwood P, et al: Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011; 25: 40-45.
38. Chez MG, et al: Elevation of tumor necrosis factor-α in cerebrospinal fluid of autistic children. Pediatr Neurol 2007; 36: 361-365. (Pubitemid 46873913)
39. Maes M, et al: Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 2002; 54: 281-291. (Pubitemid 34304221)
40. Potvin S, et al: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008; 63: 801-808. (Pubitemid 351410515)
41. Arrode-Bruses G, Bruses JL: Maternal immune activation by poly(I:C) induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. J Neuroinflammation 2012; 9: 83.
42. Meyer U, et al: Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 2006; 20: 378-388. (Pubitemid 43775782)
43. Meyer U, et al: The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006; 26: 4752-4762. (Pubitemid 44315314)
44. Gilmore JH, Jarskog LF, Vadlamudi S: Maternal poly I:C exposure during pregnancy regulates TNFα, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 2005; 159: 106-112. (Pubitemid 40126182)
45. Ratnayake U, et al: Behaviour and hippocampus-specific changes in spiny mouse neonates after treatment of the mother with the viralmimetic poly I:C at mid-pregnancy. Brain Behav Immun 2012; 26: 1288-1299.
46. Ito HT, et al: Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring. Brain Behav Immun 2010; 24: 930-941.
47. Meyer U, et al: Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008; 22: 469-486. (Pubitemid 351451821)
48. Li Q, et al: Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One 2009; 4:e6354.
49. Dickinson H, et al: A comparative study of renal function in the desert-adapted spiny mouse and the laboratory-adapted C57BL/6 mouse: response to dietary salt load. Am J Physiol Renal Physiol 2007; 293:F1093-F1098. (Pubitemid 47583941)
50. Dickinson H, Walker DW: Managing a colony of spiny mice (Acomys cahirinus) for perinatal research. ANZCCART News 2007; 20: 4-11.
51. Pietz B: The oestrous cycle of the spiny mouse (Acomys cahirinus). J Reprod Fertil 1981; 61: 453-459.
52. Ireland Z, et al: Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. BMC Dev Biol 2009; 9: 39.
53. Benveniste EN: Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 1998; 9: 259-275. (Pubitemid 29019710)
54. Deverman BE, Patterson PH: Cytokines and CNS development. Neuron 2009; 64: 61-78.
55. Jonakait GM: Cytokines in neuronal development. Adv Pharmacol 1997; 37: 35-67.
56. Jokhi PP, King A, Loke YW: Cytokine production and cytokine receptor expression by cells of the human first trimester placentaluterine interface. Cytokine 1997; 9: 126-137. (Pubitemid 27116888)
57. Paradowska E, Blach-Olszewska Z, Gejdel E: Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta 1997; 18: 441-446. (Pubitemid 27326314)
58. Silverman MN, et al: Immune modulation of the hypothalamic-pituitary- adrenal (HPA) axis during viral infection. Viral Immunol 2005; 18: 41-78. (Pubitemid 40586446)
59. Chrousos GP, Kino T: Ikaros transcription factors: flying between stress and inflammation. J Clin Invest 2005; 115: 844-848. (Pubitemid 40489388)
60. Chrousos GP: The hypothalamic-pituitaryadrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362.
61. Lee YB, Nagai A, Kim SU: Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 2002; 69: 94-103. (Pubitemid 34734169)
62. Giulian D, et al: Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 1988; 8: 709-714. (Pubitemid 18078093)
63. Rezaie P, et al: Expression of β-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 2002; 37: 64-75. (Pubitemid 34103095)
64. Hua LL, Lee SC: Distinct patterns of stimulusinducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 2000; 30: 74-81. (Pubitemid 30172154)
65. Hanisch UK: Microglia as a source and target of cytokines. Glia 2002; 40: 140-155.
66. Gibney SM, et al: Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 2013; 28: 170-181.
67. Page DT, Kuti OJ, Sur M: Computerized assessment of social approach behavior in mouse. Front Behav Neurosci 2009; 3: 48.
68. Loranger AW: Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984; 41: 157-161. (Pubitemid 14181019)
69. McLennan JD, Lord C, Schopler E: Sex differences in higher functioning people with autism. J Autism Dev Disord 1993; 23: 217-227.
70. Lord C, Schopler E, Revicki D: Sex differences in autism. J Autism Dev Disord 1982; 12: 317-330. (Pubitemid 13202147)
71. le Couteur A, et al: Autism diagnostic interview: a standardized investigator-based instrument. J Autism Dev Disord 1989; 19: 363-387. (Pubitemid 19233509)
72. Silverman JL, et al: Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 2010; 11: 490-502.
73. Shi L, et al: Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 2009; 23: 116-123.
74. Smith SEP, et al: Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007; 27: 10695-10702. (Pubitemid 47535869)
75. Ibi D, et al: Neonatal poly I:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Neurosci Res 2009; 64: 297-305.
76. Grillon C, et al: Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 1992; 32: 939-943. (Pubitemid 23024906)
77. Perry W, Geyer MA, Braff DL: Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry 1999; 56: 277-281. (Pubitemid 29125137)
78. Perry W, et al: Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 2001; 50: 418-424. (Pubitemid 32885591)
79. Perry W, et al: Sensorimotor gating deficits in adults with autism. Biol Psychiatry 2007; 61: 482-486. (Pubitemid 46185328)
80. Kumari V, Soni W, Sharma T: Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 1999; 156: 1046-1051. (Pubitemid 29302798)
81. Weike AI, Bauer U, Hamm AO: Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 2000; 47: 61-70. (Pubitemid 30016081)
82. Shi L, et al: Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003; 23: 297-302. (Pubitemid 36050430)
83. le Pen G, Moreau JL: Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 2002; 27: 1-11. (Pubitemid 34626738)
84. Wolff AR, Bilkey DK: The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav Brain Res 2010; 213: 323-327.
85. Vuillermot S, et al: A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010; 30: 1270-1287.
86. Schell AM, et al: Attentional modulation of startle in psychosis-prone college students. Psychophysiology 1995; 32: 266-273.
87. Myles-Worsley M, et al: P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol Psychiatry 2004; 55: 663-667. (Pubitemid 38376176)
88. Lee J, Park S: Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol 2005; 114: 599-611. (Pubitemid 41746997)
89. Bennetto L, Pennington BF, Rogers SJ: Intact and impaired memory functions in autism. Child Dev 1996; 67: 1816-1835. (Pubitemid 126420332)
90. Minshew NJ, Goldstein G: The pattern of intact and impaired memory functions in autism. J Child Psychol Psychiatry 2001; 42: 1095-1101. (Pubitemid 34044276)
91. Aleman A, et al: Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 1999; 156: 1358-1366. (Pubitemid 29416531)
92. Saykin AJ, et al: Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991; 48: 618-624.
93. Waltz JA, Gold JM: Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res 2007; 93: 296-303. (Pubitemid 46817948)
94. Lionello-Denolf KM, et al: Reversal learning set and functional equivalence in children with and without autism. Psychol Rec 2008; 58: 15-36.